PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)

Clinical Trial Title

The PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo

National Clinical Trial Number:

NCT04262206

Clinical Trial Protocol Description:

A large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are more than 75 years of age.
  • Do not currently have dementia, disability or clinically evident cardiovascular disease, including those with frailty, diabetes, and multi-morbidity.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Raj C. Shah, MD

Contact Information

Michael Pessman